Summary
GlobalData's Medical Devices sector report, “Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Metered Dose Inhaler Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Metered Dose Inhaler Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Metered Dose Inhaler Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Aerophase Inc.
Bespak Europe Ltd.
Globe Medical Tech, Inc.
Lab Automate Technologies Inc.
Medicom Innovation Partner a/s
Min USA LLC
Mylan N.V.
Novartis AG
Propeller Health
Rensselaer Polytechnic Institute
SkyePharma Plc
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Metered Dose Inhaler Devices Overview 5
3 Products under Development 6
3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 6
3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory 7
3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path 8
3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date 9
4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies 10
4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development 10
4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 11
5 Metered Dose Inhaler Devices Companies and Product Overview 12
5.1 Aerophase Inc. Company Overview 12
5.1.1 Aerophase Inc. Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Bespak Europe Ltd. Company Overview 13
5.2.1 Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Globe Medical Tech, Inc. Company Overview 15
5.3.1 Globe Medical Tech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.4 Lab Automate Technologies Inc. Company Overview 16
5.4.1 Lab Automate Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.5 Medicom Innovation Partner a/s Company Overview 17
5.5.1 Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview 17
5.6 Min USA LLC Company Overview 18
5.6.1 Min USA LLC Pipeline Products & Ongoing Clinical Trials Overview 18
5.7 Mylan N.V. Company Overview 19
5.7.1 Mylan N.V. Pipeline Products & Ongoing Clinical Trials Overview 19
5.8 Novartis AG Company Overview 21
5.8.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 Propeller Health Company Overview 23
5.9.1 Propeller Health Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 Rensselaer Polytechnic Institute Company Overview 24
5.10.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 24
5.11 SkyePharma Plc Company Overview 26
5.11.1 SkyePharma Plc Pipeline Products & Ongoing Clinical Trials Overview 26
6 Metered Dose Inhaler Devices- Recent Developments 28
6.1 Feb 25, 2016: Propeller Health Enters into Agreement with Aptar Pharma 28
6.2 Jun 16, 2015: Consort Medical announces final results 28
7 Appendix 34
7.1 Methodology 34
7.2 About GlobalData 36
7.3 Contact Us 37
7.4 Disclaimer 37
1.1 List of Tables
Table 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 6
Table 2: Metered Dose Inhaler Devices - Pipeline Products by Territory 7
Table 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path 8
Table 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date 9
Table 5: Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development 10
Table 6: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 11
Table 7: Aerophase Inc. Pipeline Products & Ongoing Clinical Trials Overview 12
Table 8: Metered Dose Inhaler - Product Status 12
Table 9: Metered Dose Inhaler - Product Description 12
Table 10: Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 13
Table 11: VAL020 Metered Dose Inhaler Valve - Product Status 13
Table 12: VAL020 Metered Dose Inhaler Valve - Product Description 13
Table 13: VAL310 Easifill Valve - Product Status 14
Table 14: VAL310 Easifill Valve - Product Description 14
Table 15: Globe Medical Tech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 16: Inhaler - Product Status 15
Table 17: Inhaler - Product Description 15
Table 18: Lab Automate Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 19: Ultrasonic Metered Dose Inhaler - Product Status 16
Table 20: Ultrasonic Metered Dose Inhaler - Product Description 16
Table 21: Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview 17
Table 22: Asmair - Product Status 17
Table 23: Asmair - Product Description 17
Table 24: Min USA LLC Pipeline Products & Ongoing Clinical Trials Overview 18
Table 25: Envi - Product Status 18
Table 26: Envi - Product Description 18
Table 27: Mylan N.V. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 28: Metered Dose Inhaler - Product Status 20
Table 29: Metered Dose Inhaler - Product Description 20
Table 30: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 21
Table 31: Seebri Breezhaler - Product Status 22
Table 32: Seebri Breezhaler - Product Description 22
Table 33: Propeller Health Pipeline Products & Ongoing Clinical Trials Overview 23
Table 34: Connected Metered Dose Inhaler - Product Status 23
Table 35: Connected Metered Dose Inhaler - Product Description 23
Table 36: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 24
Table 37: Bloom Inhaler - Product Status 25
Table 38: Bloom Inhaler - Product Description 25
Table 39: SkyePharma Plc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 40: Flutiform HFA-MDI - Product Status 27
Table 41: Flutiform HFA-MDI - Product Description 27
Table 42: Glossary 35
1.2 List of Figures
Figure 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development 6
Figure 2: Metered Dose Inhaler Devices - Pipeline Products by Territory 7
Figure 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path 8
Figure 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date 9
